A study of the effect of gender on interferon beta-1a (Avonex® 30 mcg) treatment in patients with multiple sclerosis

被引：0
|
作者：
Munschauer, FE
Herndon, R
Sandrock, AW
Tsao, E
Berkhoff, JE
Stubbendick, A
机构：
[1] Jacobs Neurol Inst, Buffalo, NY USA
[2] Univ Mississippi, Jackson, MS 39216 USA
[3] Biogen Idec, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [1] Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study
    Kleinschnitz, Christoph
    Niemczyk, Gabriele
    Rehberg-Weber, Karin
    Wernsdoerfer, Colin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (07): : 15271 - 15286
  • [2] Quality of life in patients with relapsing multiple sclerosis taking intramuscular interferon beta-1a (Avonex®)
    Hyde, R.
    Rudick, R. A.
    Foulds, P.
    You, X.
    JOURNAL OF NEUROLOGY, 2008, 255 : 113 - 113
  • [3] QUALITY OF LIFE IN RELAPSING REMMITING MULTIPLE SCLEROSIS: INFLUENCE OF INTERFERON BETA-1A (AVONEX AND CINNOVEX) TREATMENT
    Shahtaheri, R. S.
    Hatam, N.
    VALUE IN HEALTH, 2016, 19 (07) : A436 - A436
  • [4] Level of satisfaction of spanish multiple sclerosis patients treated with a new formulation of Avonex® (interferon beta-1A 30 MCG intramuscular, once weekly, solution for injection ready to use)
    Sanchez-Solino, O.
    Arroyo, E.
    Grau, C.
    VALUE IN HEALTH, 2008, 11 (03) : A150 - A150
  • [5] Interferon beta-1a (Avonex) increases cerebrospinal fluid interleukin-10 in patients with relapsing multiple sclerosis
    Rudick, RA
    Ransohoff, R
    Medendorp, S
    Boyle, S
    Peppler, R
    Jacobs, L
    Cockfair, D
    Herndon, R
    Richert, J
    Salazar, A
    Fischer, J
    Granger, C
    Simon, J
    Goodkin, D
    Wende, K
    ANNALS OF NEUROLOGY, 1996, 40 (03) : T244 - T244
  • [6] Long-term follow-up of multiple sclerosis patients treated with interferon beta-1a (Avonex®)
    Vermersch, R
    Denève, M
    Waucquier, N
    de Seze, J
    MULTIPLE SCLEROSIS, 2005, 11 : S75 - S75
  • [7] EFFECT OF INTERFERON BETA-1A SC ON DEMYELINATION IN MULTIPLE SCLEROSIS PATIENTS
    Zivadinov, Robert
    Dwyer, Michael G.
    Markovic-Plese, Silva
    Kennedy, Cheryl
    Bergsland, Niels
    Ramasamy, Deepa P.
    Durfee, Jacqueline
    Hojnacki, David
    Hayward, Brooke
    Dangond, Fernando
    Weinstock-Guttman, Bianca
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1414 - 1414
  • [8] Response to interferon beta-1a treatment in African American multiple sclerosis patients
    Cree, BAC
    Al-Sabbagh, A
    Bennett, R
    Goodin, D
    ARCHIVES OF NEUROLOGY, 2005, 62 (11) : 1681 - 1683
  • [9] Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis
    Sandberg-Wollheim, M
    Frank, D
    Goodwin, TM
    Giesser, B
    Lopez-Bresnahan, M
    Stam-Moraga, M
    Chang, P
    Francis, GS
    NEUROLOGY, 2005, 65 (06) : 802 - 806
  • [10] Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a
    Mohr, DC
    Likosky, W
    Boudewyn, AC
    Marietta, P
    Dwyer, P
    Van Der Wende, J
    Goodkin, DE
    MULTIPLE SCLEROSIS, 1998, 4 (06): : 487 - 489
12345